Betaklav 500 mg/125 mg film - coated tablets  Bulgarie - bulgare - Изпълнителна агенция по лекарствата

betaklav 500 mg/125 mg film - coated tablets 

krka, d.d. novo mesto - Амоксицилин и инхибитор на ензима - 500 mg/125 mg film - coated tablets 

Betaklav 875 mg/125 mg film - coated tablets  Bulgarie - bulgare - Изпълнителна агенция по лекарствата

betaklav 875 mg/125 mg film - coated tablets 

krka, d.d. novo mesto - Амоксицилин и инхибитор на ензима - 875 mg/125 mg film - coated tablets 

Betaklav 400 mg/57 mg/5 ml powder for oral suspension Bulgarie - bulgare - Изпълнителна агенция по лекарствата

betaklav 400 mg/57 mg/5 ml powder for oral suspension

krka, d.d. novo mesto - Амоксицилин и инхибитор на ензима - 400 mg/57 mg/5 ml powder for oral suspension

Betaderm A 0,5 mg/g + 30 mg/g ointment Bulgarie - bulgare - Изпълнителна агенция по лекарствата

betaderm a 0,5 mg/g + 30 mg/g ointment

pharmaswiss ceska republika s.r.o. - 0,5 mg/g + 30 mg/g ointment

Betaloc ZOK 50 mg prolonged - release tablets  Bulgarie - bulgare - Изпълнителна агенция по лекарствата

betaloc zok 50 mg prolonged - release tablets 

astra zeneca ab - Метопролол - 50 mg prolonged - release tablets 

Betaloc ZOK 100 mg prolonged - release tablets  Bulgarie - bulgare - Изпълнителна агенция по лекарствата

betaloc zok 100 mg prolonged - release tablets 

astra zeneca ab - Метопролол - 100 mg prolonged - release tablets 

Betadine 200 mg pessaries Bulgarie - bulgare - Изпълнителна агенция по лекарствата

betadine 200 mg pessaries

egis pharmaceuticals public limited company - Повидон-йод - 200 mg pessaries

Cevenfacta Union européenne - bulgare - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - Антихеморагични - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

Cystadane Union européenne - bulgare - EMA (European Medicines Agency)

cystadane

recordati rare diseases - Бетаин безводен - Хомоцистинурията - Други стомашно-чревния тракт и обмяната на веществата средства, - adjunctive treatment of homocystinuria, involving deficiencies or defects in:cystathionine beta-synthase (cbs);5,10-methylene-tetrahydrofolate reductase (mthfr);cobalamin cofactor metabolism (cbl). cystadane should be used as supplement to other therapies such as vitamin b6 (pyridoxine), vitamin b12 (cobalamin), folate and a specific diet.

Betaderm 0,5 mg/g + 1 mg/g cream Bulgarie - bulgare - Изпълнителна агенция по лекарствата

betaderm 0,5 mg/g + 1 mg/g cream

0,5 mg/g + 1 mg/g cream